Mahon, François Xavier
France Intergroupe de la leucémie myéloïde chronique Fi-LMC,
France
2025 Rank: 42,183
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,268 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42,183 | 42,546 |
| Total Cites | 17,646 | 21,076 |
| H-index | 58 | 61 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 20 | 20 |
| Total Cites to Single Authored Papers | 166 | 183 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 3,128 | 3,489 |
| Number of Single+First+Last Authored Papers | 107 | 107 |
| Total Cites to Single+First+Last Authored Papers | 6,150 | 6,844 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10,762 | 11,929 |
| Ratio of Total Citations to Distinct Citing Papers | 1.64 | 1.77 |
| Self-Citation Percentage |
16.27%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,250 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40,501 | 40,763 |
| Total Cites | 16,543 | 19,741 |
| H-index | 57 | 61 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 20 | 20 |
| Total Cites to Single Authored Papers | 158 | 173 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 3,029 | 3,373 |
| Number of Single+First+Last Authored Papers | 106 | 106 |
| Total Cites to Single+First+Last Authored Papers | 5,930 | 6,574 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10,147 | 11,254 |
| Ratio of Total Citations to Distinct Citing Papers | 1.63 | 1.75 |
| Self-Citation Percentage |
16.20%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,249 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40,064 | 40,732 |
| Total Cites | 15,370 | 18,361 |
| H-index | 54 | 58 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 20 | 20 |
| Total Cites to Single Authored Papers | 154 | 169 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 2,930 | 3,271 |
| Number of Single+First+Last Authored Papers | 106 | 106 |
| Total Cites to Single+First+Last Authored Papers | 5,648 | 6,278 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9,519 | 10,576 |
| Ratio of Total Citations to Distinct Citing Papers | 1.61 | 1.74 |
| Self-Citation Percentage |
16.29%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,281 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39,864 | 39,810 |
| Total Cites | 14,106 | 16,870 |
| H-index | 51 | 55 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 20 | 20 |
| Total Cites to Single Authored Papers | 140 | 155 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 2,796 | 3,131 |
| Number of Single+First+Last Authored Papers | 105 | 105 |
| Total Cites to Single+First+Last Authored Papers | 5,327 | 5,941 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,825 | 9,805 |
| Ratio of Total Citations to Distinct Citing Papers | 1.60 | 1.72 |
| Self-Citation Percentage |
16.38%
|
|
Trending Researchers
.jpeg)
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.